Is HER2-positive metastatic breast cancer still an incurable disease?

Lancet Oncol. 2020 Apr;21(4):471-472. doi: 10.1016/S1470-2045(20)30058-9. Epub 2020 Mar 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Breast Neoplasms*
  • Docetaxel
  • Double-Blind Method
  • Humans
  • Receptor, ErbB-2
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Docetaxel
  • Receptor, ErbB-2
  • pertuzumab
  • Trastuzumab